Don't miss out! There are still a few tickets remaining for our most exciting event of the year 🎉➡️ shorturl.at/mKJiu If you have been on the fence, this is your very last chance to join 400+ of the sector's finest for an unforgettable evening of cocktails, canapés and high-level networking.

Congratulations to BIA member RQ Biotechnology Ltd. on closing an oversubscribed $115 million Series A! ➡️ sl1nk.com/uqlvjno The funding will advance RQB01, which is designed to deliver potent and broad protection against #Influenza through a differentiated dual mechanism of action.

What a great start to #BIO2026 in San Diego! Thank you to everyone who joined us. It was wonderful to see so many members & familiar friendly faces plus make the acquaintance of many new people. We look forward to building on these relationships throughout the week. 📌@uktradebusiness.bsky.social

Houdini Bio has officially launched, having raised approximately £1.5 million in non-dilutive grant funding and an oversubscribed pre-seed round. 🎉 shorturl.at/1UZkl Their machine learning-guided DNA sequence design platform is designed to overcome the human cell mistaking DNA for a viral invader.

The UK has been selected as Guest Country at @Biospain 2026, and we are inviting UK organisations to join the delegation! ➡️ lnkd.in/e8PsrWwn To join the UK delegation and receive your discounted registration code, contact patrick.jodar@fcdo.gov.uk or jessica.griffiths@fcdo.gov.uk.

The UK’s life sciences sector is world-class - and Northern Ireland is a vital part of that story. BIA CEO and Chair are pleased to be in Belfast yesterday celebrating NI’s contribution to our national pipeline. Huge thanks to the HIRANI team for the warm welcome.

Our April roundup of Lab bench to front bench is out! ➡️ shorturl.at/VAyga In this edition we cover our influence activity in April, including: 🔸 How BIA is strengthening UK medicine manufacturing 🔸 What we've been reading and listening to 🔸 What's coming up across BIA Policy and Public Affairs

$2.1 billion. That is the scale of the Series B funding secured by Isomorphic Labs, a landmark moment for #UKBiotech 🔗➡️ shorturl.at/9cgDx The funding will accelerate AI Drug Design Engine, and bringing AI, engineering and clinical talent together to tackle biological and medical challenges.

Today, we publish BIA's health data vision 2035: harnessing a national asset for growth. ➡️ shorturl.at/G00kY The report sets out how the UK can securely use its health data as a strategic national asset to drive economic growth, improve patient outcomes, and support long-term NHS sustainability.

While financing in Q1 2026 sits below last year's peak, Q1 2025 was influenced by a small number of megadeals. A look beneath the data reveals an uptick in activity. ➡️ biotechfinance.org Deal volume is up 67%. Twenty-five transactions were completed this quarter, compared to just 15 in Q1 2025.

Global uncertainty and technological convergence are reshaping the sector, and the pressure on leaders to adapt has never been greater. 🔗➡️ shorturl.at/p44l2 Join us at #WomeninBiotech at Alderley Park for an evening exploring how leaders are managing organisational change.

We are excited to announce the official launch of our report on Unlocking investment in #UKbiosolutions ➡️ lnkd.in/ewnJKAjD The £1.46 billion raised by the UK biosolutions sector since 2018 signals a strong and steadily growing industry. Read the full report in the link above

The UK #LifeSciences sector continues to grow, bringing with it exciting new job opportunities that are driving innovation and improving patient outcomes. Visit our website to explore sector jobs ➡️ shorturl.at/FpLqb

If you enjoyed our #WomeninBiotech tours, we’re excited to announce that Women in Biotech is coming to Alderley Park! 🔗 ➡️ shorturl.at/TXh0t Join us for an engaging event exploring representation and diversity across the sector. This event is open to all, don’t miss out! 🎟️ Book your ticket above ⤴️

Our latest edition of Lab bench to front bench is out now! ➡️ shorturl.at/GfN06 In this edition, we take a look back at February and the ways we've kept life sciences and our members at the top of the political agenda. #LabBenchToFrontBench #UKLifeSciences

Three challenges across the year to raise vital funds for individuals living with #MuscularDystrophy ➡️ shorturl.at/QmrcQ 🚴 Pedal Paddle Peak 🏃 Bidwells Oxford 10K 🏃 Bidwells Cambridge 10K Help drive progress in research and shine a spotlight on 110,000 people living with muscle-wasting conditions.

In the run-up to Rare Diseases Day on Saturday, Emily Klein, has written a blog reflecting on the importance of #RareDiseaseDay in bringing visibility to those affected by a rare condition and serving as a focal point for advocacy in this space. 🧬🧑‍⚕️ Read the blog ➡️ lnkd.in/eq6ymypd

Katherine Powers and Max Stanyard (RSM) examine how regulatory reform, data-driven partnerships, and smarter cross-border operating models are creating new pathways for growth across both markets. Read the full blog ➡️ www.bioindustry.org/resource/res... #LifeSciences

Influencing policy and government is a major part of BIA's work. That's why our Policy is excited to announce our new monthly blog series, #LabBenchtoFrontBench. Each edition will showcase our influencing activity across the month. Read our first edition ➡️ shorturl.at/VMPpF #UKLifeSciences

We welcome the fantastic news from FUJIFILM Biotechnologies on the opening of state-of-the-art #Biomanufacturing and process development facilities in the UK. This investment is a strong vote of confidence in the UK as a place to build, scale & deliver globally competitive #LifeSciences capability.

#Biosolutions are reshaping food, agriculture, materials and #Biofuels, powering both economic growth and the transition to #NetZero. These innovations are essential for transitioning from fossil fuel dependency to a sustainable bioeconomy. Register your attendance today ➡️ shorturl.at/myR4I

The latest UK biotech financing insights are now live! Our findings show that 2025 was a year of strategic resilience as the UK stood its ground in a tough global market. ➡️ biotechfinance.org Our message to the government and #Investors is clear: it’s time to deliver and deploy. #InvestinBiotech

We kicked off Cohort 4 for the #WomeninBiotech Mentoring Program, and what an energising start it was! We brought together an exceptional group of mentors and mentees from across the biotech ecosystem to support each other in their career aspirations and personal development.

BIA’s new policy report, ‘Innovation to impact: unlocking patient access to rare disease medicines’, is out. ➡️ lnkd.in/eYUbx9jR Developed by BIA's RDIG, the report builds on the MHRA's plans to develop a new regulatory pathway for #RareDiseaseTherapies. Explore full insights in the link above.

Yesterday, the Science, Innovation and Technology Committee questioned Steve as Chair of the Office for Life Sciences, Samantha Roberts, Lord Vallance, and Dr Zubir Ahmed MP, to scrutinise what the government is doing to boost the UK’s global competitiveness in #LifeSciences.

Take a look at our newly released UK biotech financing Q3 report➡️ biotechfinance.org Now is the time to double down on #Investment & the #IndustrialStrategy, not pursue short-term cost savings. The long-term economic & social returns from supporting life science outweigh immediate fiscal pressures.

Secure your Early Bird tickets for the 22nd Annual #BioProcessUK Conference before they expire! ➡️ shorturl.at/IZPif Don’t miss this opportunity to forge valuable business connections, stay updated on the latest #bioprocessing innovations, and gain insights from industry-leading speakers.

In the latest edition of #PULSE: Empowering the future of UK #biotech, we take a closer look at MarraBio ➡️ shorturl.at/dPxIG MarraBio is an innovative company focused on developing cutting-edge solutions at the intersection of #Biology and #Technology. Read the case study in the link above

"London Life Sciences Week (LLSW) is going to collect the best companies, investors and academics in the UK here to London. But more than that, it’s now attracting people from overseas." Ros Deegan, CEO of @omasstx.bsky.social 🧪 Visit: lifesciencesweek.london

Are you excited for the RNA Vaccines and Therapeutics Conference? 👉 shorturl.at/56E8C Hosted by @CPI, @imperialcollegeldn.bsky.social, and BIA, this two-day event will spotlight the latest breakthroughs in encoded #RNAmedicines. 📅 23–24 September 2025 📍 London, The Royal College of Physicians